Encompass Health Corporation
EHC
$107.93
-$1.02-0.94%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.25% | 28.08% | 30.84% | 31.29% | 29.46% |
| Total Depreciation and Amortization | 9.45% | 9.53% | 12.44% | 10.06% | 9.38% |
| Total Amortization of Deferred Charges | -1.03% | 2.11% | 2.11% | 2.11% | 2.11% |
| Total Other Non-Cash Items | 23.95% | 28.34% | 24.72% | 21.38% | 30.77% |
| Change in Net Operating Assets | -80.37% | -164.76% | 631.11% | 48.15% | -56.46% |
| Cash from Operations | 17.23% | 19.83% | 26.71% | 22.15% | 17.87% |
| Capital Expenditure | -14.61% | -7.67% | -1.29% | -6.99% | -10.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -161.11% | -950.00% | -3,171.43% | -174.14% | 45.18% |
| Cash from Investing | -17.04% | -10.83% | -4.66% | -8.53% | -8.38% |
| Total Debt Issued | 121.05% | 161.54% | 110.00% | 5.00% | 18.75% |
| Total Debt Repaid | 29.08% | -45.46% | -291.06% | -118.84% | -106.37% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -312.04% | -204.75% | -209.52% | -558.73% | -426.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.22% | -13.84% | -10.54% | -6.92% | -3.97% |
| Other Financing Activities | -979.89% | -411.34% | 36.09% | 72.94% | 138.41% |
| Cash from Financing | -30.43% | -131.25% | -147.98% | -133.82% | -67.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -206.88% | -282.32% | -259.07% | -193.45% | -62.80% |